WUXI XDC Trademark

Trademark Overview


On Monday, July 3, 2023, a trademark application was filed for WUXI XDC with the United States Patent and Trademark Office. The USPTO has given the WUXI XDC trademark a serial number of 98069930. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, July 18, 2024. This trademark is owned by WuXi XDC Cayman Inc.. The WUXI XDC trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of Antibody-drug Conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates; processing of pharmaceutical preparations; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of Antibody drugs; processing of biomedical preparations; processing of biotechnology drug

Development of products for others in the field of pharmaceuticals; pharmaceutical drug development services; research and development of new products in the field of pharmaceuticals; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates; preclinical research and evaluation of new drugs; consulting services in the field of technology development; research and development of new products for others; scientific research and development
wuxi xdc

General Information


Serial Number98069930
Word MarkWUXI XDC
Filing DateMonday, July 3, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, July 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesCustom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of Antibody-drug Conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates; processing of pharmaceutical preparations; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of Antibody drugs; processing of biomedical preparations; processing of biotechnology drug
Description of MarkThe mark consists of the stylized wording "WuXi XDC", with "XDC" partially inside an incomplete oval outline that intersects with another incomplete oval outline.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDevelopment of products for others in the field of pharmaceuticals; pharmaceutical drug development services; research and development of new products in the field of pharmaceuticals; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates; preclinical research and evaluation of new drugs; consulting services in the field of technology development; research and development of new products for others; scientific research and development

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, August 3, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWuXi XDC Cayman Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Cayman KY1-1104
KY

Party NameWuXi XDC Cayman Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KY1-1104
KY

Trademark Events


Event DateEvent Description
Thursday, July 6, 2023NEW APPLICATION ENTERED
Thursday, August 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 4, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, October 31, 2023ASSIGNED TO EXAMINER
Wednesday, November 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 18, 2024SOU EXTENSION 1 FILED
Thursday, July 18, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 18, 2024SOU TEAS EXTENSION RECEIVED